3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
30
Peritoneal Neoplasms
24
Ovarian Neoplasms
24
Fallopian Tube Neoplasms
13
Carcinoma, Ovarian Epithelial
12
Colorectal Neoplasms
11
Neoplasm Metastasis
5
Appendiceal Neoplasms
5
Recurrence
3
Pancreatic Neoplasms
3
Neoplasms
3
Uterine Neoplasms
2
Sarcoma
2
Pseudomyxoma Peritonei
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Carcinoma
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Stage â…¢ Gastric Cancer
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Interventions
Cisplatin
176
Paclitaxel
79
Radiotherapy
76
Carboplatin
70
Brachytherapy
69
pembrolizumab
63
Bevacizumab
40
Gemcitabine
28
Radiation
27
Topotecan
26
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
25
Nivolumab
22
Colposcopy
22
human papillomavirus vaccine, L1 type 16, 18
21
Magnetic Resonance Spectroscopy
21
atezolizumab
19
Platinum
19
Drug Therapy
19
Papillomavirus Vaccines
18
Radiotherapy, Intensity-Modulated
17
Docetaxel
17
Taxes
16
Cyclophosphamide
16
Biopsy
16
Early Intervention, Educational
15
1,2-diaminocyclohexaneplatinum II citrate
15
Methods
14
Blood Specimen Collection
14
fludarabine
13
Injections
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Uterine Cervical Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled